The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
118849495 11884949 5 F 20131223 20160825 20160104 20160831 EXP CA-ROCHE-1164835 ROCHE 65.73 YR F Y 0.00000 20160831 CN CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
118849495 11884949 1 PS XOLAIR OMALIZUMAB 1 Subcutaneous U S0065E,S0001E 103976 225 MG SOLUTION FOR INJECTION QOW
118849495 11884949 2 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0065E,S0001E 103976 SOLUTION FOR INJECTION
118849495 11884949 3 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0065E,S0001E 103976 225 MG SOLUTION FOR INJECTION QOW
118849495 11884949 4 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0065E,S0001E 103976 SOLUTION FOR INJECTION
118849495 11884949 5 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0065E,S0001E 103976 SOLUTION FOR INJECTION
118849495 11884949 6 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0065E,S0001E 103976 SOLUTION FOR INJECTION
118849495 11884949 7 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0065E,S0001E 103976 SOLUTION FOR INJECTION
118849495 11884949 8 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0065E,S0001E 103976 SOLUTION FOR INJECTION
118849495 11884949 9 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0065E,S0001E 103976 SOLUTION FOR INJECTION
118849495 11884949 10 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0065E,S0001E 103976 SOLUTION FOR INJECTION
118849495 11884949 11 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0065E,S0001E 103976 SOLUTION FOR INJECTION
118849495 11884949 12 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0065E,S0001E 103976 SOLUTION FOR INJECTION
118849495 11884949 13 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0065E,S0001E 103976 SOLUTION FOR INJECTION

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
118849495 11884949 1 Asthma

Outcome of event

Event ID CASEID OUTC COD
118849495 11884949 HO
118849495 11884949 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
118849495 11884949 Asthma
118849495 11884949 Blood pressure diastolic decreased
118849495 11884949 Blood pressure increased
118849495 11884949 Body temperature decreased
118849495 11884949 Breast cancer recurrent
118849495 11884949 Dyspnoea
118849495 11884949 Fatigue
118849495 11884949 Nervousness
118849495 11884949 Tachycardia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
118849495 11884949 1 20101129 0
118849495 11884949 2 20121017 0
118849495 11884949 3 20121128 0
118849495 11884949 4 20131223 0
118849495 11884949 5 20141203 0
118849495 11884949 6 20150128 0
118849495 11884949 7 20150225 0
118849495 11884949 8 20150715 0
118849495 11884949 9 20151229 0
118849495 11884949 10 20160420 0
118849495 11884949 11 20160519 0
118849495 11884949 12 20160602 0
118849495 11884949 13 20160616 0